Full text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

According to the food addiction (FA) model, the consumption of certain types of food could be potentially addictive and can lead to changes in intake regulation. We aimed to describe metabolic parameters, dietary characteristics, and affective and neurocognitive vulnerabilities of individuals with and without FA, and to explore its influences on weight loss progression. The sample included 448 adults (55–75 years) with overweight/obesity and metabolic syndrome from the PREDIMED-Plus cognition sub-study. Cognitive and psychopathological assessments, as well as dietary, biochemical, and metabolic measurements, were assessed at baseline. Weight progression was evaluated after a 3-year follow up. The presence of FA was associated with higher depressive symptomatology, neurocognitive decline, low quality of life, high body mass index (BMI), and high waist circumference, but not with metabolic comorbidities. No differences were observed in the dietary characteristics except for the saturated and monounsaturated fatty acids consumption. After three years, the presence of FA at baseline resulted in a significantly higher weight regain. FA is associated with worse psychological and neurocognitive state and higher weight regain in adults with metabolic syndrome. This condition could be an indicator of bad prognosis in the search for a successful weight loss process.

Details

Title
Metabolic, Affective and Neurocognitive Characterization of Metabolic Syndrome Patients with and without Food Addiction. Implications for Weight Progression
Author
Camacho-Barcia, Lucía 1   VIAFID ORCID Logo  ; Lucero Munguía 1   VIAFID ORCID Logo  ; Lucas, Ignacio 1   VIAFID ORCID Logo  ; de la Torre, Rafael 2   VIAFID ORCID Logo  ; Salas-Salvadó, Jordi 3   VIAFID ORCID Logo  ; Pintó, Xavier 4   VIAFID ORCID Logo  ; Corella, Dolores 5   VIAFID ORCID Logo  ; Granero, Roser 6   VIAFID ORCID Logo  ; Jiménez-Murcia, Susana 7   VIAFID ORCID Logo  ; González-Monje, Inmaculada 5 ; Esteve-Luque, Virginia 8   VIAFID ORCID Logo  ; Cuenca-Royo, Aida 9 ; Gómez-Martínez, Carlos 10 ; Paz-Graniel, Indira 10 ; Forcano, Laura 9 ; Fernández-Aranda, Fernando 7   VIAFID ORCID Logo 

 Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Hospitalet de Llobregat, 08907 Barcelona, Spain or [email protected] (L.C.-B.); [email protected] (L.M.); or [email protected] (I.L.); [email protected] (S.J.-M.) 
 CIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain; [email protected] (R.d.l.T.); [email protected] (J.S.-S.); [email protected] (X.P.); [email protected] (D.C.); [email protected] (R.G.); [email protected] (I.G.-M.); [email protected] (A.C.-R.); [email protected] (C.G.-M.); [email protected] (I.P.-G.); [email protected] (L.F.); Integrative Pharmacology and Neurosciences Systems, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain; Department of Experimental and Health Sciences (CEXS-UPF), Universitat Pompeu Fabra, 08002 Barcelona, Spain 
 CIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain; [email protected] (R.d.l.T.); [email protected] (J.S.-S.); [email protected] (X.P.); [email protected] (D.C.); [email protected] (R.G.); [email protected] (I.G.-M.); [email protected] (A.C.-R.); [email protected] (C.G.-M.); [email protected] (I.P.-G.); [email protected] (L.F.); Universitat Rovira i Virgili, Department of Biochemistry and Biotechnology, Human Nutrition Unit, Reus, 43201 Tarragona, Spain; Institut d’Investigació Pere Virgili (IISPV), Reus, 43204 Tarragona, Spain; The Sant Joan University Hospital, Human Nutrition Unit, 43201 Reus, Spain 
 CIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain; [email protected] (R.d.l.T.); [email protected] (J.S.-S.); [email protected] (X.P.); [email protected] (D.C.); [email protected] (R.G.); [email protected] (I.G.-M.); [email protected] (A.C.-R.); [email protected] (C.G.-M.); [email protected] (I.P.-G.); [email protected] (L.F.); Lipids and Vascular Risk Unit, Internal Medicine, University Hospital of Bellvitge-IDIBELL, Hospitalet de Llobregat, 08907 Barcelona, Spain; [email protected]; Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Hospitalet de Llobregat, 08907 Barcelona, Spain 
 CIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain; [email protected] (R.d.l.T.); [email protected] (J.S.-S.); [email protected] (X.P.); [email protected] (D.C.); [email protected] (R.G.); [email protected] (I.G.-M.); [email protected] (A.C.-R.); [email protected] (C.G.-M.); [email protected] (I.P.-G.); [email protected] (L.F.); Department of Preventive Medicine, University of Valencia, 46010 Valencia, Spain 
 CIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain; [email protected] (R.d.l.T.); [email protected] (J.S.-S.); [email protected] (X.P.); [email protected] (D.C.); [email protected] (R.G.); [email protected] (I.G.-M.); [email protected] (A.C.-R.); [email protected] (C.G.-M.); [email protected] (I.P.-G.); [email protected] (L.F.); Department of Psychobiology and Methodology, Autonomous University of Barcelona, 08193 Barcelona, Spain 
 Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Hospitalet de Llobregat, 08907 Barcelona, Spain or [email protected] (L.C.-B.); [email protected] (L.M.); or [email protected] (I.L.); [email protected] (S.J.-M.); CIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain; [email protected] (R.d.l.T.); [email protected] (J.S.-S.); [email protected] (X.P.); [email protected] (D.C.); [email protected] (R.G.); [email protected] (I.G.-M.); [email protected] (A.C.-R.); [email protected] (C.G.-M.); [email protected] (I.P.-G.); [email protected] (L.F.); Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Hospitalet de Llobregat, 08907 Barcelona, Spain 
 Lipids and Vascular Risk Unit, Internal Medicine, University Hospital of Bellvitge-IDIBELL, Hospitalet de Llobregat, 08907 Barcelona, Spain; [email protected] 
 CIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain; [email protected] (R.d.l.T.); [email protected] (J.S.-S.); [email protected] (X.P.); [email protected] (D.C.); [email protected] (R.G.); [email protected] (I.G.-M.); [email protected] (A.C.-R.); [email protected] (C.G.-M.); [email protected] (I.P.-G.); [email protected] (L.F.); Integrative Pharmacology and Neurosciences Systems, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain 
10  CIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain; [email protected] (R.d.l.T.); [email protected] (J.S.-S.); [email protected] (X.P.); [email protected] (D.C.); [email protected] (R.G.); [email protected] (I.G.-M.); [email protected] (A.C.-R.); [email protected] (C.G.-M.); [email protected] (I.P.-G.); [email protected] (L.F.); Universitat Rovira i Virgili, Department of Biochemistry and Biotechnology, Human Nutrition Unit, Reus, 43201 Tarragona, Spain; Institut d’Investigació Pere Virgili (IISPV), Reus, 43204 Tarragona, Spain 
First page
2779
Publication year
2021
Publication date
2021
Publisher
MDPI AG
e-ISSN
20726643
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2565482239
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.